Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FXGVR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,446
Award facts
- Contract value 100% obligated
- $12,446.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $12,446.14 to DMS Pharmaceutical Group Inc. for the supply of 52 mg Mirena systems, contraceptive devices used in federal military healthcare operations. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received this award without set-aside designation on November 3, 2025, with an ultimate completion date of November 25, 2025. The delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply chains across Department of Defense healthcare facilities worldwide.
This delivery order represents one of numerous orders issued to DMS Pharmaceutical Group under the PPV-G GEN V framework, which authorizes the company to supply a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, vaccines, and medical consumables to military healthcare facilities globally. DMS Pharmaceutical Group's prime vendor contract under this program, designated SPE2DR, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning the company as a critical regional pharmaceutical supplier for Department of Defense operations. The company's demonstrated capability across diverse product categories and consistent performance on prior delivery orders validates its role within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FXGVR?
SPE2DB26FXGVR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FXGVR worth?
The government has obligated $12,446 on SPE2DB26FXGVR.
Is contract SPE2DB26FXGVR an order under another contract?
Yes. SPE2DB26FXGVR is a delivery order under SPE2DB25D9306, an indefinite delivery contract.
Was contract SPE2DB26FXGVR competed?
The extent of competition for SPE2DB26FXGVR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award